{
  "code": 0,
  "message": "Success",
  "zpData": {
    "pageType": 0,
    "selfAccess": false,
    "securityId": "eRZsqRuss2eh0-C1DPZ8vEvKNFhtGb9QfNegPaQK3ZWcFrY1rbGPRg6wfs9YpQQA86Uv4Oc3bCiB4QnFW5Yhknhq2gKhCQKtfSsm-SuLgJhUnhSYTg~~",
    "sessionId": null,
    "lid": "",
    "jobInfo": {
      "encryptId": "1a0197bbbf9e21ca1HJ72ty-FFFT",
      "encryptUserId": "1b335b5fcbb1e3b70Xd82t-_GFY~",
      "invalidStatus": false,
      "jobName": "纯化技术员",
      "position": 210117,
      "positionName": "药品生产",
      "location": 101190400,
      "locationName": "苏州",
      "experienceName": "1-3年",
      "degreeName": "大专",
      "jobType": 0,
      "proxyJob": 0,
      "proxyType": 0,
      "salaryDesc": "5-6K",
      "payTypeDesc": null,
      "postDescription": "负责单抗药品的纯化操作",
      "encryptAddressId": "6ea9f532016058901Hx42dy_F1c~",
      "address": "苏州吴中区信达生物制药集团168号",
      "longitude": 120.740702,
      "latitude": 31.259701,
      "staticMapUrl": "https://img.bosszhipin.com/beijin/amap/staticMap/3f2a3d0e881633fcd03d14d1320b95ab",
      "pcStaticMapUrl": "https://img.bosszhipin.com/beijin/amap/staticMap/c774f689660756b98038dace17a1362e",
      "overseasAddressList": [],
      "overseasInfo": null,
      "showSkills": [
        "药学相关专业",
        "生物药",
        "生产操作",
        "中药",
        "化学药"
      ],
      "anonymous": 0,
      "jobStatusDesc": "招聘中"
    },
    "bossInfo": {
      "name": "姜先生",
      "title": "高级经理",
      "tiny": "https://img.bosszhipin.com/beijin/upload/avatar/20210303/87690a5e0baa3fc1c6a4a9ba6f435df5137989023ebe35bbe3209d035ce_b.jpg",
      "large": null,
      "activeTimeDesc": "今日活跃",
      "bossOnline": false,
      "brandName": "信达生物",
      "bossSource": 0,
      "certificated": true,
      "tagIconUrl": null,
      "avatarStickerUrl": null
    },
    "brandComInfo": {
      "encryptBrandId": "5b2c49a66bd86e321HF92d2_Fw~~",
      "brandName": "信达生物",
      "logo": "https://img.bosszhipin.com/beijin/mcs/banner/575dcf5ec29d575153887ac3bb1f8c36cfcd208495d565ef66e7dff9f98764da.jpg",
      "stage": 807,
      "stageName": "已上市",
      "scale": 305,
      "scaleName": "1000-9999人",
      "industry": 100401,
      "industryName": "生物/制药",
      "introduce": "“始于信，达于行”，开发出老百姓用得起的高质量生物药，是信达生物的使命和目标。信达生物成立于2011年，致力于研发、生产和销售肿瘤、自身免疫、代谢、眼科等重大疾病领域的创新药物，让我们的工作惠及更多的生命。公司已有11个产品获得批准上市，它们分别是信迪利单抗注射液（达伯舒®），贝伐珠单抗注射液（达攸同®），阿达木单抗注射液（苏立信®），利妥昔单抗注射液（达伯华®），佩米替尼片（达伯坦®），奥雷巴替尼片（耐立克®）， 雷莫西尤单抗注射液（希冉择®），塞普替尼胶囊（睿妥®），伊基奥仑赛注射液（福可苏®），托莱西单抗注射液（信必乐®）和氟泽雷塞片（达伯特®）。目前，同时还有3个品种在NMPA审评中，4个新药分子进入III期或关键性临床研究，另外还有18个新药品种已进入临床研究。\n\n公司已与礼来、罗氏、赛诺菲、Adimab、Incyte和MD Anderson 癌症中心等国际合作方达成30多项战略合作。信达生物在不断自研创新药物、谋求自身发展的同时，秉承经济建设以人民为中心的发展思想。多年来，始终心怀科学善念，坚守“以患者为中心”，心系患者并关注患者家庭，积极履行社会责任。公司陆续发起、参与了多项药品公益援助项目，让越来越多的患者能够得益于生命科学的进步，买得到、用得起高质量的生物药。截至目前，信达生物患者援助项目已惠及17余万普通患者，药物捐赠总价值34亿元人民币。信达生物希望和大家一起努力，提高中国生物制药产业的发展水平，以满足百姓用药可及性和人民对生命健康美好愿望的追求。",
      "labels": [
        "五险一金",
        "补充医疗保险",
        "定期体检",
        "加班补助",
        "年终奖",
        "股票期权",
        "带薪年假",
        "餐补",
        "交通补助",
        "包吃",
        "节日福利"
      ],
      "activeTime": 1726367782929,
      "visibleBrandInfo": true,
      "focusBrand": false,
      "customerBrandName": "信达生物",
      "customerBrandStageName": "已上市"
    },
    "oneKeyResumeInfo": {
      "inviteType": 0,
      "alreadySend": false,
      "canSendResume": false,
      "canSendPhone": false,
      "canSendWechat": false
    },
    "relationInfo": {
      "interestJob": false,
      "beFriend": false
    },
    "handicappedInfo": null,
    "appendixInfo": {
      "canFeedback": false
    },
    "atsOnlineApplyInfo": {
      "inviteType": 0,
      "alreadyApply": false
    }
  }
}